Join the Northwestern Medicine Neurology Team for an In-Person CME Event

Audience
This course is designed for all healthcare providers involved in the diagnosis and treatment of patients with neurological disorders including neurologists, family medicine physicians, general practice physicians, internal medicine physicians and advanced providers.

Accreditation Statement
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this educational activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery Continuous Certification Program
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Event details

Northwestern Medicine Updates in Neurology Symposium
Friday, October 10 | 7:30am - 4:00pm

Breakfast and lunch will be provided. 

Course description
This neurology symposium will provide attendees with a comprehensive overview of contemporary, clinically relevant content on the care of patients with neurological disorders. We will cover a broad range of topics including neurological manifestations of COVID-19, multiple sclerosis, migraines, epilepsy, neuromuscular disease, dizziness and more. Recent advances in the field will be covered and their direct clinical relevance will be highlighted.

Course directors
Eunice Torres, MD, Paul Later, MD, and Rimas Lukas, MD

Program objectives
After attending this educational activity, participants should be able to:

• Recognize and apply evidence-based treatments for neurological subspecialties including headaches, multiple sclerosis, memory disorders, epilepsy, movement disorders, neuro-oncology, stroke, and oto-neurology.
• Recognize and apply the fundamental basis and modalities of neurotherapeutics in neurological subspecialties.
• Review current controversies in the care of patients within neurological subspecialties.
• Identify indications for use of newer medications and treatment modalities in neurological subspecialties.
• Examine the use for genetics in neurological subspecialties including movement disorders and epilepsy.

Presentations

Approach to New/Controversial Medications for Cognitive Neurology Patients

Speaker: Borna Bonakdarpour, MD, FAAN, FANA, Associate Professor of Neurology

Specialty: Behavioral Neurology

Details: Explore recent developments in pharmacotherapy for cognitive disorders, including an analysis of emerging medications, their efficacy and controversies surrounding their use in clinical practice.

Long-COVID: Cognitive Impairments & Rehabilitation

Speaker: Igor J Koralnik, MD, Chief of Neuro-infectious Disease and Global Neurology, Archibald Church Professor of Neurology

Specialty: Neuro-infectious Disease and Global Neurology

Details: This presentation will focus on neurological complications of long COVID, including cognitive dysfunction, and rehabilitation strategies to support patient recovery and quality of life.

Evaluating & Treating the Dizzy Patient

Speaker: Nicholas Hac, MD, Assistant Professor of Neurology

Specialty: Hospital Neurology and Comprehensive Neurology

Details: Focused on diagnostic approaches for patients presenting with dizziness, this session will cover differential diagnoses, assessment tools and management strategies to improve patient outcomes.

Neurological Toxicities From Oncology Treatments

Speaker: Anas Alshawa, MD, Neuro-oncologist

Specialty: Neuro-oncology

Details: Review the various neurological toxicities associated with cancer therapies, examining recognition, management and preventive strategies to mitigate risks for patients undergoing treatment.

Approach to Migraine Management

Speaker: Jenny Ji-Hyun Lee, MD, Instructor of Neurology

Specialty: Comprehensive Neurology

Details: This sessions focuses on evidence-based approaches for managing migraines, including pharmacologic and non-pharmacologic therapies, lifestyle modifications and patient education techniques.

Treatment of Movement Disorders

Speaker: Juan Deliz Gonzalez, MD

Specialty: Movement Disorders

Details: Get updates in diagnosing and treating various movement disorders, including Parkinson's disease, dystonia and essential tremor. The session highlights innovative therapeutic options.

Interesting Cases in MS & Neuroimmunology

Speaker: Shailee S. Shah, MD, Clinical Assistant Professor, Neurology

Specialty: MS/Neuroimmunology

Details: The session will cover unique and challenging cases in multiple sclerosis and neuroimmunology, focusing on diagnostic dilemmas, treatment challenges and lessons learned from clinical practice.

Epilepsy in Women

Speaker: Alexa M. King, MD, Assistant Professor, Neurology

Specialty: Epilepsy/Clinical Neurophysiology

Details: This presentation covers considerations in managing epilepsy in women, addressing hormonal influences, pregnancy and the impact of childbirth on seizure control and medication management.

New Therapies for Patients With Chronic Inflammatory Demyelinating Polyneuropathy & Myasthenia Gravis

Speaker: Shubadra Priyadarshini, MD, Assistant Professor of Neurology

Specialty: Neurology

Details: The session covers recent advances in treatment for CIDP and myasthenia gravis, including newly approved therapies and ongoing clinical trials aiming to improve patient outcomes.

Approach to Insomnia & Circadian Disorders

Speaker: Phyllis C. Zee, MD, PhD, Director, Center for Circadian and Sleep Medicine, Chief of Sleep Medicine

Specialty: Sleep Medicine

Details: Get an overview of insomnia and circadian rhythm disorders, including diagnostic criteria, treatment modalities and the role of sleep hygiene.